Blood biomarkers for heart attack detection
Pro Research Analysisby 
Searched over 200M research papers
Key Blood Biomarkers for Heart Attack Detection
Blood biomarkers are essential tools for detecting heart attacks (acute myocardial infarction, AMI). Over the years, several types of biomarkers have been identified and used in clinical practice, each reflecting different aspects of heart injury and disease progression Țilea2021Xu2022Netala2025+1 MORE.
Cardiac Troponins: The Gold Standard
Cardiac troponins (cTnI and cTnT) are currently the most accurate and widely used biomarkers for diagnosing heart attacks. They are highly sensitive and specific for detecting cardiac muscle damage, making them the gold standard in clinical settings Țilea2021Netala2025Pant2012+1 MORE. High-sensitivity troponin tests can detect even small amounts of heart muscle injury, but their increased sensitivity can sometimes reduce specificity, leading to false positives in non-heart attack conditions .
Early and Emerging Biomarkers
While troponins are effective, they may not rise immediately after a heart attack begins, leaving a diagnostic gap in the very early stages. Newer biomarkers are being explored to address this limitation:
- Heart-type Fatty Acid Binding Protein (H-FABP) and Myoglobin: These proteins rise earlier than troponins and can help detect heart attacks sooner Netala2025Jian2024Lyngbakken2018.
- Cardiac-specific microRNAs (e.g., miR-208a): These nucleic acids increase rapidly in the blood after a heart attack and show promise for very early detection, with high sensitivity and specificity Xu2022Netala2025Wang2010.
- Copeptin: This marker reflects neurohormonal activation and, when combined with troponin, can improve early diagnosis Netala2025Jian2024Lyngbakken2018.
- Glycogen Phosphorylase Isoenzyme BB (GPBB) and Ischemia-Modified Albumin (IMA): These indicate early myocardial ischemia and damage .
Inflammatory and Stress-Related Biomarkers
Heart attacks trigger inflammation and stress responses in the body, leading to the release of additional biomarkers:
- C-reactive Protein (CRP) and Interleukin-6 (IL-6): These markers indicate inflammation and are associated with heart attack severity and prognosis Netala2025Jian2024Lyngbakken2018.
- Growth Differentiation Factor 15 (GDF-15) and Soluble Suppressor of Tumorigenicity 2 (ST2): These are linked to cardiac stress and remodeling Netala2025Lyngbakken2018Castiglione2021.
- Galectin-3: Associated with fibrosis and heart failure risk after a heart attack Netala2025Lyngbakken2018Castiglione2021.
Natriuretic Peptides and Heart Failure Markers
Although primarily used for heart failure, B-type Natriuretic Peptide (BNP) and N-terminal proBNP (NT-proBNP) can also provide information about heart attack severity and risk of complications Netala2025Jian2024Lyngbakken2018+3 MORE.
Multi-Biomarker and Multi-Omic Approaches
Recent advances allow for the simultaneous measurement of multiple biomarkers, improving diagnostic accuracy and risk assessment. Technologies like antibody microarrays can detect several markers at once, such as troponin, H-FABP, CRP, copeptin, myoglobin, D-dimer, and NT-proBNP, offering high sensitivity and specificity for distinguishing heart attacks from other conditions Țilea2021Netala2025Jian2024.
Novel and Future Directions
Research continues to identify new biomarkers, including microRNAs and long non-coding RNAs, which may allow for even earlier and more precise detection of heart attacks. Multi-omic approaches that combine genetic, protein, and metabolic data are also being explored to further refine diagnosis and treatment Țilea2021Xu2022Netala2025.
Conclusion
Blood biomarkers are crucial for the early and accurate detection of heart attacks. Cardiac troponins remain the primary tool, but new and emerging markers—such as H-FABP, microRNAs, copeptin, and inflammatory proteins—are enhancing early diagnosis and risk assessment. Multi-marker and multi-omic strategies promise to further improve patient outcomes by enabling faster and more precise detection of heart attacks Țilea2021Xu2022Netala2025+3 MORE.
Sources and full results
Most relevant research papers on this topic